Veterinary Medicines

Fortekor Vet. tabletter 2,5 mg

Authorised
  • Benazepril hydrochloride
  • Benazepril hydrochloride
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Fortekor Vet. 2,5 mg tabletter
Fortekor Vet. tabletter 2,5 mg
Active substance:
  • Benazepril hydrochloride
  • Benazepril hydrochloride
  • Benazepril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Benazepril hydrochloride
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Benazepril hydrochloride
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Novartis Sante Animale
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 38617
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 2,5 MG)
Published on: 19/08/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."